Fig. 1

Insulin Discontinuation and Glycemic Control. The figure represents the patients for whom HbA1c measurements were available (1588 out of 2957 patients who discontinued and 2100 out of 4052 patients who did not discontinue insulin therapy at baseline; 2584 out of 2957 patients who discontinued and 3547 out of 4052 patients who did not discontinue insulin therapy at end-of-study). Circles represent mean values. Wisps indicate standard error. Paired t-test was used to determine statistical significance (only for the 3580 patients who had both baseline and end-of-study HbA1c measurements available)